Halozyme Therapeutics reported $491.68M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Amarin AMRN:US $ 222.88M 104.14M
Amgen AMGN:US $ 11969M 5339M
Aptinyx Inc APTX:US $ 125.29M 3.94M
Arena Pharmaceuticals ARNA:US $ 386.65M 127.52M
Baxter International BAX:US $ 3258M 122M
Cara Therapeutics CARA:US $ 22.99M 656K
Cytokinetics CYTK:US $ 477.64M 440.48M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Esperion Therapeutics ESPR:US $ 103.67M 115.51M
Halozyme Therapeutics HALO:US $ 491.68M 44.72M
Immunogen IMGN:US $ 245.76M 6.22M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
Intra Cellular Therapies ITCI:US $ 106.13M 14.9M
Intrexon XON:US $ 41.73M 5.32M
Jazz Pharmaceuticals JAZZ:US 1000 0
Mannkind MNKD:US $ 51.74M 10.78M
Minerva Neurosciences NERV:US $ 65.59M 8.63M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Peregrine Pharmaceuticals PPHM:US $ 163.68M 3.98M
Rigel Pharmaceuticals RIGL:US $ 30.4M 54.42M
United Therapeutics UTHR:US $ 908.5M 33.7M
Vanda Pharmaceuticals VNDA:US $ 50.52M 6.72M